Basics ClearPoint Neuro, Inc. Common Stock IPO Date: May 1, 2012 Sector: Healthcare Industry: Medical Devices Market Cap: $389.2M Activated in VL: True Average Daily Range Avg Daily Range: $0.34 | 3.28% Avg Daily Range (30 D): $0.47 | 3.85% Avg Daily Range (90 D): $0.45 | 3.20% Institutional Daily Volume Avg Daily Volume: .07M Avg Daily Volume (30 D): .22M Avg Daily Volume (90 D): .21M Trade Size Avg Trade Size (Sh.): 89 Avg Trade Size (Sh.) (30 D): 62 Avg Trade Size (Sh.) (90 D): 61 Institutional Trades Total Inst.Trades: 45 Avg Inst. Trade: $2.88M Avg Inst. Trade (30 D): $1.86M Avg Inst. Trade (90 D): $2.55M Avg Inst. Trade Volume: .25M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $5.96M Avg Closing Trade (30 D): $2.64M Avg Closing Trade (90 D): $3.29M Avg Closing Volume: 523.05K         News Nov 20, 2024 @ 9:30 AM Global MRI Guided Neurosurgical Ablation Market Po... Source: Sabyasachi Ghosh Jun 20, 2024 @ 12:45 PM ClearPoint Neuro Congratulates Partner Aspen Neuro... Source: ClearPoint Neuro, Inc. Jun 3, 2024 @ 3:53 PM ClearPoint's (CLPT) New Products to Boost Neurosur... Source: Zacks Equity Research Jun 1, 2024 @ 1:00 PM ClearPoint Neuro Announces Full Market Release of ... Source: ClearPoint Neuro, Inc. May 29, 2024 @ 1:55 PM Does ClearPoint Neuro (CLPT) Have the Potential to... Source: Zacks Equity Research Financials   TTM Q4 2024 FY 2024 Basic EPS $-.7 $-.2 $-.7 Diluted EPS $-.7 $-.2 $-.7 Revenue $ 31.39M $ 7.77M $ 31.39M Gross Profit $ 19.12M $ 4.76M $ 19.12M Net Income / Loss $ -18.91M $ -5.39M $ -18.91M Operating Income / Loss $ -19.75M $ -5.6M $ -19.75M Cost of Revenue $ 12.27M $ 3.01M $ 12.27M Net Cash Flow $ -3.04M $ -1.47M $ -3.04M PE Ratio     Splits Jul 27, 2015:   35:1